NCT04192630 - A Study of B + L Ophthalmic Viscosurgical Device (OVD) CVisc50 | Biotech Hunter

Enrollment

390

Participants

Timeline

Start Date

November 26, 2019

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions

Cataract

Interventions

DEVICE

CVisc50 OVD

Bausch + Lomb CVisc50 Cohesive OVD

DEVICE

ProVisc OVD

PROCEDURE

Cataract Surgery

Trial Locations (22)

10013

Bausch Site 005, New York

37073

Bausch Site 014, Goodlettsville

37215

Bausch 018, Nashville

45040

Bausch Site 021, Mason

55420

Bausch Site 019, Bloomington

63090

Bausch Site 015, Washington

63131

Bausch Site 002, St Louis

64154

Bausch Site 020, Kansas City

72704

Bausch Site 008, Fayetteville

77008

Bausch Site 006, Houston

78215

Bausch 022, San Antonio

78229

Bausch Site 016, San Antonio

78613

Bausch Site 009, Cedar Park

85032

Bausch Site 001, Phoenix

85224

Bausch Site 017, Chandler

90505

Bausch Site 004, Torrance

91325

Bausch Site 012, Northridge

92662

Bausch Site 011, Newport Beach

92843

Bausch Site 007, Garden Grove

94010

Bausch Site 010, Burlingame

95670

Bausch Site 013, Rancho Cordova

96002

Bausch Site 003, Reading

All Listed Sponsors

lead

Bausch & Lomb Incorporated

INDUSTRY